Cargando…
A Systematic Study on Zinc-Related Metabolism in Breast Cancer
Breast cancer has become the most common cancer worldwide. Despite the major advances made in the past few decades in the treatment of breast cancer using a combination of chemotherapy, endocrine therapy, and immunotherapy, the genesis, treatment, recurrence, and metastasis of this disease continue...
Autores principales: | Qu, Zheng, Liu, Qiang, Kong, Xiangyi, Wang, Xiangyu, Wang, Zhongzhao, Wang, Jing, Fang, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10096741/ https://www.ncbi.nlm.nih.gov/pubmed/37049543 http://dx.doi.org/10.3390/nu15071703 |
Ejemplares similares
-
Comprehensive Analysis of the Expressionand Prognosis for TDO2 in Breast Cancer
por: Liu, Qiang, et al.
Publicado: (2020) -
Molecular and Clinical Characterization of LAG3 in Breast Cancer Through 2994 Samples
por: Liu, Qiang, et al.
Publicado: (2021) -
Conditional Survival of female patients with operable invasive Breast Cancer in US: A population-based study
por: Ai, Bolun, et al.
Publicado: (2020) -
Pretreatment Systemic Inflammation Response Index in Patients with Breast Cancer Treated with Neoadjuvant Chemotherapy as a Useful Prognostic Indicator
por: Chen, Li, et al.
Publicado: (2020) -
Pre‐treatment systemic immune‐inflammation index is a useful prognostic indicator in patients with breast cancer undergoing neoadjuvant chemotherapy
por: Chen, Li, et al.
Publicado: (2020)